Adagio Medical Holdings Cash Flow Statement (2023-2026) | ADGM

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -9.56M-6.84M-9.57M-32.96M-4.76M-9.24M-5.33M-11.29M-4.61M-6.80M
Depreciation and Depletion (Quarter) 0.10M0.10M0.30M0.30M0.20M0.30M0.20M0.50M0.20M0.20M
Share-based Compensation (Quarter) 0.11M0.11M0.11M0.22M0.23M0.14M0.89M0.39M
Gains from Investment Securities (Quarter) 0.02M-0.04M0.08M-0.09M-4.97M-0.04M0.14M0.23M-0.35M0.13M
Asset Writedowns and Impairment (Quarter) 0.00M0.08M-0.04M-0.01M
Cash from Operations (Quarter) -7.09M-6.74M-6.47M-6.36M-7.21M-4.11M-4.13M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.01M0.01M
Depreciation & Amortization (CF) (Quarter) 0.10M0.13M0.33M0.32M0.32M0.27M0.20M0.50M0.24M0.21M
Change in Working Capital
Change in Receivables (Quarter) -0.00M-0.07M0.13M-0.01M-0.03M-0.00M0.02M
Change in Inventory (Quarter) 3.03M0.28M1.04M0.13M-0.26M0.12M-0.07M
Change in Account Payables (Quarter) 0.88M1.94M-0.36M-0.19M0.06M0.14M
Change in Accured Expenses (Quarter) -0.22M0.68M0.96M-0.65M-0.58M-1.50M0.14M
Other Working Capital Changes (Quarter) -1.08M-0.04M-0.04M-0.02M0.01M0.00M
Investing Activities
Capital Expenditures (Quarter) -0.31M0.16M0.00M0.58M0.34M-0.49M0.00M
Cash from Investing Activities (Quarter) -0.02M-0.16M-0.00M-0.58M-0.34M0.49M-0.00M
Financing Activities
Other financing activities (Quarter) 0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 10.00M10.00M5.50M
Change in Capital Stock
Shares Issued (Quarter) 0.75M0.74M0.01M0.01M5.70M1.10M5.79M9.45M
Misc.
Cash from Financing Activities (Quarter) 6.58M9.57M5.07M
Exchange Rate Effect (Quarter) -0.07M0.03M0.12M0.04M-0.08M-0.06M-0.07M
Change in Cash (Quarter) -0.60M2.70M8.29M-6.89M-7.62M12.43M-4.20M
Free Cash Flow (Quarter) -6.79M-6.90M-6.47M-6.94M-7.55M-3.62M-4.13M
Net Cash Flow (Quarter) -0.53M2.67M-1.40M-6.94M-7.55M-3.62M-4.13M